Detalhe da pesquisa
1.
Association between coffee and tea consumption and ovarian cancer incidence: A prospective analysis in the PLCO dataset.
Int J Cancer;
2024 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38733325
2.
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.
J Transl Med;
19(1): 415, 2021 10 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34620163
3.
Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
Exp Cell Res;
395(2): 112212, 2020 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32771525
4.
Severe hyponatremia in preeclampsia: a case report and review of the literature.
Arch Gynecol Obstet;
303(4): 925-931, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33033866
5.
Successful pregnancy after complete resection of leiomyomatosis peritonealis disseminate without recurrence:a case report with next-generation sequencing analysis and literature review.
World J Surg Oncol;
18(1): 85, 2020 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32359372
6.
BRCA mutation frequency and clinical features of ovarian cancer patients: A report from a Chinese study group.
J Obstet Gynaecol Res;
45(11): 2267-2274, 2019 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31411802
7.
PCNA-associated factor P15PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.
Int J Cancer;
143(11): 2973-2984, 2018 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30129654
8.
A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer.
Int J Gynecol Cancer;
28(1): 51-58, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28976449
9.
The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.
Int J Gynecol Cancer;
27(8): 1650-1657, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28692638
10.
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse.
J Ovarian Res;
16(1): 209, 2023 Oct 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37891662
11.
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy.
J Oncol;
2022: 4880355, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35466318
12.
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer.
Front Oncol;
12: 861392, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35651784
13.
Clinical features and prognostic factors analysis of intravenous leiomyomatosis.
Front Surg;
9: 1020004, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36793517
14.
Parallel Loop Binding Compression Suture, a Modified Procedure for Pernicious Placenta Previa Complicated With Placenta Increta.
Front Surg;
8: 786497, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34912843
15.
Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study.
Front Oncol;
11: 810099, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35071013
16.
Enhanced Recovery After Surgery Impact on the Systemic Inflammatory Response of Patients Following Gynecological Oncology Surgery: A Prospective Randomized Study.
Cancer Manag Res;
13: 4383-4392, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34103993
17.
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer.
Clin Cancer Res;
27(9): 2452-2458, 2021 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33558426
18.
Overexpression of PRC1 indicates a poor prognosis in ovarian cancer.
Int J Oncol;
56(3): 685-696, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31922238
19.
Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingo-oophorectomy with a poor prognosis: A case report and review of the literature.
World J Clin Cases;
7(22): 3872-3880, 2019 Nov 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31799317
20.
FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Int J Oncol;
52(6): 2130-2142, 2018 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29620165